Grant Projects
Artemis Bioservices has ample expertise in virology, immunology and vaccinology, and participates as principal investigators and partners in several national, international and EU-funded projects.
InFLUenza virus UNIVersal VACcine development program
The FLUNIVAC consortium was funded by the European Commission under the FP7 program. Artemis was involved in the evaluation of induction of broad protective immune responses of vaccine candidates, using appropriate animal models. Several assays were develop...
ViewKnowledge on Lyssavirus
The ASKLEPIOS consortium was funded by the European Commission, under the FP7 program. The goal of ASKLEPIOS was to identify rational targets for the development of novel therapeutic leads against rabies encephalitis by targeting both viral replication and ...
ViewAssessment of influenza vaccines
The FLUCOP consortium, funded by IMI, evaluated the use of cell-mediated immunity and neuraminidase assays as tools for assessing influenza vaccine performance. Artemis was involved in the development of novel analytical approaches to population-based evalu...
ViewRadical innovation in vaccine development
Supported by EUREKA Eurostars, DRIVE is a consortium consisting of four EU partners, funded by their national subsidy point. DRIVE makes use of virus-like particles (VLP) evolution to develop vaccine candidates against dengue virus. Their immunogenicity, sa...
ViewNew perspectives for brain therapeutics
Funded by IMI, IM2PACT tackles the unmet challenge of discovery and characterization of blood-brain barrier targets and transport mechanisms for brain delivery of therapeutics to treat neurodegenerative and metabolic diseases. Artemis is in charge of unders...
ViewZoonoses Anticipation and Preparedness Initiative
Funded by IMI, ZAPI aims at shortening the time to adequately respond to emerging infectious diseases using a One Health approach. Artemis is involved in developing tests for the evaluation of vaccine immunogenicity, avidity, neutralizing titers, glycosylat...
View